Caligan Partners »

Ocuphire Pharma shares owned by Caligan Partners

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by Caligan Partners from 13F filings

Historical chart of Caligan Partners investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by Caligan Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by Caligan Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $28M 6.1M 4.55

More positions owned by Caligan Partners

Liquidia Corporation Com New (LQDA)
Revolution Medicines (RVMD)
Abivax Sa Sponsored Ads (ABVX)
Vaxcyte (PCVX)
Xenon Pharmaceuticals (XENE)
Mineralys Therapeutics (MLYS)
Exelixis (EXEL)
Cg Oncology Call Option (CGON)
Tango Therapeutics (TNGX)
Tyra Biosciences (TYRA)
Adma Biologics (ADMA)
Spyre Therapeutics Com New (SYRE)
Lb Pharmaceuticals Com Shs (LBRX)
Vor Biopharma Com New (VOR)
Sab Biotherapeutics Com New (SABS)

View all positions for Caligan Partners

Top funds holding Ocuphire Pharma

Caligan Partners
Adage Capital Partners GP
BIOS Capital Management
Balyasny Asset Management
Millennium Management
Vanguard Capital Management
Vanguard Group
Marshall Wace
Boxer Capital Management
ADAR1 Capital Management
Perceptive Advisors
Nantahala Capital Management
Woodline Partners
Boothbay Fund Management
Opaleye Management

View all funds holding Ocuphire Pharma